Vol 15, No 2 (April 30, 2026): Chinese Clinical Oncology

First-line fulvestrant vs. anastrozole in hormone receptor-positive advanced breast cancer: insights from the final FALCON trial results

First-line programmed death-1 blockade plus chemotherapy in low programmed cell death ligand 1 esophageal squamous cell carcinoma: beyond a single biomarker

Targeting metabolism in acute myeloid leukemia: the next therapeutic frontier?

Hormone therapy in younger women: reassessing risk narratives in the era of precision menopausal care

Eribulin and trastuzumab in early-line HER2-positive metastatic breast cancer: evaluating an active chemotherapy partner in an evolving treatment landscape

Is rechallenge with CDK4/6 inhibitors beyond progression reasonable for patients with hormone receptor-positive and HER2-negative advanced breast cancer?—a commentary on the PALMIRA trial

Fos-related antigen 1 is required for Helicobacter pylori-induced inflammatory response in gastric epithelial cells through NF-κB pathway

Short- and long-term outcomes after laparoscopic versus open total gastrectomy for stage 0–I gastric cancer: a multicenter, retrospective analysis

TP63 drives TKI resistance in EGFR-mutant lung cancer via ferroptosis inhibition

Impact of neoadjuvant chemotherapy vs. upfront surgery on survival in early-onset colorectal cancer—a single centre experience

Genome-wide 5-hydroxymethylcytosine in circulating cell-free DNA reflects DNA methylation dynamics for non-invasive detection of early hepatocellular carcinoma

Surgical management of pancreatic cancer: an overview

Small cell lung cancer: a therapeutic update in the era of immunotherapy and beyond—a narrative review

A narrative review of the value of immunoinflammatory markers in the prognosis of endometrial carcinoma

Claudin 18.2 testing in gastroesophageal and pancreatobiliary cancers: current status, clinical implications and challenges

Benign metastasizing leiomyoma: a systematic review of diagnosis, management, and outcomes

Advances and applications of liquid biopsy approaches in hepatopancreatobiliary (HPB) cancers: a literature review

Role of androgen receptor signaling in chemoresistance in urothelial cancer: a narrative review

Advancing precision oncology through innovative and adaptive master protocol designs: statistical, operational, and regulatory perspectives